4.8 Article

Mono- and biallelic variant effects on disease at biobank scale

Journal

NATURE
Volume 613, Issue 7944, Pages 519-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41586-022-05420-7

Keywords

-

Ask authors/readers for more resources

Identifying causal factors for Mendelian and common diseases is an ongoing challenge in medical genetics. This study utilizes the history of the Finnish population and finds that population bottleneck events enrich some homozygous variants to higher frequencies, facilitating the identification of variants that cause diseases with recessive inheritance. The results show associations for homozygous genotypes across a broad spectrum of phenotypes, including known associations and novel associations.
Identifying causal factors for Mendelian and common diseases is an ongoing challenge in medical genetics(1). Population bottleneck events, such as those that occurred in the history of the Finnish population, enrich some homozygous variants to higher frequencies, which facilitates the identification of variants that cause diseases with recessive inheritance(2,3). Here we examine the homozygous and heterozygous effects of 44,370 coding variants on 2,444 disease phenotypes using data from the nationwide electronic health records of 176,899 Finnish individuals. We find associations for homozygous genotypes across a broad spectrum of phenotypes, including known associations with retinal dystrophy and novel associations with adult-onset cataract and female infertility. Of the recessive disease associations that we identify, 13 out of 20 would have been missed by the additive model that is typically used in genome-wide association studies. We use these results to find many known Mendelian variants whose inheritance cannot be adequately described by a conventional definition of dominant or recessive. In particular, we find variants that are known to cause diseases with recessive inheritance with significant heterozygous phenotypic effects. Similarly, we find presumed benign variants with disease effects. Our results show how biobanks, particularly in founder populations, can broaden our understanding of complex dosage effects of Mendelian variants on disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available